摘要
目的对匙萼金丝桃(Hypericum uralum)化学成分进行分离鉴定;对部分成分的镇痛与β-羟高铁血红素形成抑制活性进行测试。方法利用硅胶、Sephadex LH-20等材料柱色谱和现代波谱技术对匙萼金丝桃体积分数95%乙醇提取物乙酸乙酯部分化学成分进行分离和结构鉴定;采用小鼠乙酸扭体法、热水甩尾法和β-羟高铁血红素形成抑制实验对部分单体化合物进行生物活性测试。结果从匙萼金丝桃体积分数95%乙醇提取物乙酸乙酯部位中分离得到13个化合物,分别鉴定为(-)-圣草素(1),3,4,5-三羟基(口山)酮(2),1,7-二羟基(口山)酮(3),4-羟基-2,3-二甲氧基(口山)酮(4),toxyloxanthone B(5),1,3,6,7-四羟基酮(6),2,3-二甲氧基(口山)酮(7),1,5,6-三羟基-3-甲氧基(口山)酮(8),hyperielliptone HD(9),3,3',4,4'-四羟基联苯(10),莽草酸(11),槲皮素-3-O-(4″-甲氧基)-α-L-鼠李糖(12)和原花青素A-2(13)。镇痛活性测试结果表明,化合物3和12具有一定的外周镇痛活性;同时,化合物1表现出较强的β-羟高铁血红素形成抑制活性。结论化合物1~13均为首次从该植物中分离得到;匙萼金丝桃镇痛与抗疟活性具有相应物质基础。
OBJECTIVE To study the chemical constituents of Hypericum uralum were isolated and identified and test the analgesic activity andβ-hematin formation inhibitory activity of some selected compounds.METHODS The compounds were isolated and purified by column chromatography padded with the separating material including silica gel and Sephadex LH-20,and their structures were elucidated based on the analyses of modern spectrum technology.Analgesic and antimalarial activities of selected compounds from H.uralum were evaluated by acetic acid-induced writhing,hot water tail-flick test in mice,andβ-hematin formation inhibition method,respectively.RESULTS Thirteen compounds were isolated from ethyl acetate portion of 95%ethanol extract of H.uralum and identified as(-)-eriodictyol(1),3,4,5-trihydroxyxanthone(2),1,7-dihydroxyxanthone(3),4-hydroxy-2,3-dimethoxyxanthone(4),toxyloxanthone B(5),1,3,6,7-tetrahydroxyxanthone(6),2,3-dimethoxyxanthone(7),1,5,6-trihydroxy-3-methoxyxanthone(8),hyperielliptone HD(9),3,3’,4,4’-tetrahydroxybiphenyl(10),shikimic acid(11),quercetin-3-O-(4″-methoxy)-α-L-rahmnopyranosyl(12),and proanthocyanidin A-2(13).The analgesic activity test indicated that compounds 3 and 12 had certain peripheral analgesic activity,while compound 1 exhibited strongβ-hematin formation inhibitory activity.CONCLUSION All the compounds are obtained from this plant for the first time.The analgesic and antimalarial activities of H.uralum have corresponding material basis.
作者
刘健
肖朝江
崔淑君
李阳
董相
姜北
LIU Jian;XIAO Chao-jiang;CUI Shu-jun;LI Yang;DONG Xiang;JIANG Bei(Institute of Materia Medica&College of Pharmacy and Chemistry,Dali University,Dali 671000,China)
出处
《中国药学杂志》
CAS
CSCD
北大核心
2019年第8期614-619,共6页
Chinese Pharmaceutical Journal
基金
国家自然科学基金项目资助(81460532
81641187)